ROR␣1 and RVR are orphan members of the superfamily of nuclear hormone receptors which constitutively activate and repress, respectively, gene transcription by binding to a common DNA sequence. In an attempt to understand the physiological functions of these two transcription factors, we aimed to identify target genes. We have identified a consensus binding site for ROR␣1 and RVR in the first intron of the N-myc gene that we designated N-myc RORE (ROR response element). Unlike most of the intronic sequence, the region encompassing the N-myc RORE is highly conserved between human and mouse, underscoring its importance. Our studies revealed that ROR␣1 and RVR specifically bind to the human and mouse N-myc ROREs and transactivate and transrepress, respectively, reporter constructs containing the ROREs. 
N-Myc is a member of a family of nuclear phosphoproteins consisting of products of three well-characterized genes, c-myc, N-myc, and L-myc, which possess oncogenic activity (27) . Deregulated expression of all three myc genes has been implicated in the genesis or progression of naturally occurring tumors as well as in the transformation of cultured cells in cooperation with activated Ha-ras (3, 24, 38, 49) . In normal tissues, the precise function of the N-myc gene product remains unclear. The gene is primarily expressed in the developing embryo (5, 17, 32, 51) and is essential for normal organogenesis (2, 40) . N-myc expression is absent from normal adult tissues, but high levels of transcript have been observed in tumors of neuroendocrine and embryonic origin. These include Wilms' tumor, neuroblastoma, retinoblastoma, and small-cell lung carcinoma (SCLC) (20, 21, 26, 33, 37) . Moreover, this tumor distribution correlates strongly with N-myc-specific expression during normal development (51) , suggesting that neoplasia may result from a deregulation of N-myc in tissues that expressed it during organogenesis.
Amplification of the gene appears to be the predominant mechanism by which N-myc is activated in most tumors (20, 21, 26, 33, 37) . However, a subset of aggressive neuroblastomas lack amplification but express high levels of N-myc (42, 43) . Furthermore, deregulation of N-myc gene expression in SCLC cell lines not only has been attributed to gene amplification but also may be secondary to increased promoter activity (27) . Therefore, the lack of a strict correlation between high levels of N-myc expression and gene amplification suggests that overexpression of N-myc may also result from changes in the activity of specific transcriptional regulators.
In contrast to the wealth of information accumulated during the last 10 years on the regulation of c-myc transcription, the molecular basis for the control of N-myc expression remains to be elucidated. The structure of the N-myc gene is closely related to that of the c-myc gene, including the utilization of multiple transcription initiation sites (22) . However, the N-myc gene has a single major promoter that contains a TATA box and Sp1 and AP2 binding sites (4) . It has been demonstrated that major regulatory elements are located within 1 kb upstream of the major transcriptional start site of the human N-myc gene and in the first exon and intron of the gene (16) . Furthermore, murine and human regulatory elements are functionally equivalent, as the human gene was appropriately expressed in transgenic mice (16) . The regulatory elements present in the first intron of N-myc are involved in the downregulation of the gene (16, 31, 43, 44, (46) (47) (48) , and transcriptional attenuation was proposed as one of the mechanisms responsible for this effect (46) . It remains possible, however, that the negative regulatory elements located in the first intron act as binding sites for transcriptional repressors (48) . To date, no transcriptional factor known to regulate N-myc expression has been identified and/or functionally characterized.
Orphan nuclear receptors now constitute a large subgroup of the superfamily of steroid/thyroid/retinoid receptors for which no ligand has been identified. The ROR (also termed RZR) subfamily of receptors is encoded by three different genes: ␣, which produces four isoforms; ␤; and ␥ (1, 14, 18, 35) . The Rev-Erb subgroup contains two members, Rev-Erb␣ (25, 30, 39) and RVR (or Rev-Erb␤) (6, 8, 36) . ROR␣1 and RVR bind DNA as monomers to a common sequence (referred to as a ROR response element [RORE]) composed of a single half site PuGGTCA preceded by a 6-bp AT-rich region (6, 8, 12, 14, 29, 36) . While ROR␣1 appears to act as a constitutive transcriptional activator in the absence of exogenously added ligand, RVR lacks the activation function (AF-2) normally present at the carboxy-terminal end of the ligand binding domain and, through direct interaction with the transcriptional corepressor N-CoR, represses basal as well as ROR␣1-mediated promoter activity (8, 15, 36, 50) . This finding suggests that ROR␣1 and RVR may differentially regulate transcription in cells where they are coexpressed depending on their respective levels of expression. However, target genes responsive to both ROR␣ and RVR remain to be identified. In this study, we report the identification of a binding site for these orphan receptors in the first intron of the N-myc gene, a region of the gene thought to be involved in its transcriptional regulation. We demonstrate that ROR␣1 and RVR differentially control the transcription of the N-myc gene, an observation that identifies these proteins as the first known modulators of N-myc expression.
MATERIALS AND METHODS
Oligonucleotides and plasmid construction. Oligonucleotides used in this study were designed with SalI and BamHI cohesive ends. The following oligonucleotides and their complements were used as probes for electrophoretic mobility shift assay (EMSA): RORE␣2, 5Ј-TCGACTCGTATAACTAGGTCA AGCGCTG-3Ј; human N-myc RORE, 5Ј-TCGACTCGTCAATCTGGGTCAA GCGCTG-3Ј; mouse N-myc RORE, 5Ј-TCGAGAGTGATAATGTAGGTCAC GGCTG-3Ј; and mouse mutant m1 N-myc RORE with 4-bp substitutions (underlined), 5Ј-TCGAGAGTGATACTGGAGATTACGGCTG-3Ј. These oligonucleotides were introduced into TKLUC (41) in one or three copies to create reporter genes RORE␣2TKLUC, human N-mycRORETKLUC, mouse NmycRORETKLUC, and mouse mN m1 -mycRORETKLUC. In constructs containing three copies of the ROREs, each binding site was separated by an 18-bp spacer in a head-to-tail configuration. Plasmid TKLUC contains sequences Ϫ105 to ϩ51 of the thymidine kinase promoter linked to the firefly luciferase gene. All constructs were confirmed by sequencing. RSVmN-myc and RSVmN m1 -myc were constructed as follows. The entire transcriptional unit of the N-myc gene (a 7.3-kb EcoRI genomic fragment; gift of C. Asselin, Sherbrooke University) and mN m1 -myc (see below) were digested with NarI, blunted with the Klenow fragment of DNA polymerase, and ligated to NotI linkers. After digestion with NotI, the fragments were introduced into pRC/RSV (InVitrogen).
Site-directed mutagenesis. The 7.3-kb EcoRI N-myc genomic fragment was subcloned into the EcoRI site of plasmid pBluescript II KS (Stratagene) in the reverse orientation and transformed into competent Escherichia coli CJ236 (dut ung) cells on a 2ϫYT plate containing 0.25 g of uracil and 50 g of ampicillin per ml. CJ236 cells containing the N-myc plasmid were used to synthesize single-stranded DNA with the M13 helper phage. The mutant N-myc RORE oligonucleotide was used for mutagenesis by the method of Kunkel et al. (23) . The mutant constructs were identified by sequencing.
In vitro synthesis of proteins and EMSA. Plasmids pCMX-hROR␣1 (14) and pCMX-mRVR (36) were used to synthesize human ROR␣1 and mouse RVR proteins in vitro, using rabbit reticulocyte lysates (RRL) with a TNT-T7 kit (Promega, Madison, Wis.). Probes for EMSA were radiolabeled by end filling with the Klenow fragment of DNA polymerase. Approximately 0.1 ng of probe was used in each reaction with a total of 1 l (ROR␣1) and 10 l (RVR) of programmed RRL in a buffer containing 10 mM Tris-HCl (pH 8.0), 40 mM KCl, 6% glycerol, 1 mM dithiothreitol, and 0.05% Nonidet P-40 in a final volume of 25 l. To prevent single-stranded binding, 10 ng of a nonspecific oligonucleotide was included in the binding reaction. As a control, probes were also incubated with the same amount of unprogrammed lysate. Complexes were resolved on a 4% nondenaturing polyacrylamide gel in 0.5ϫ Tris-borate-EDTA.
Cell culture and transfection assays. COS-1 and P19 embryonic carcinoma (EC) cells were maintained in alpha minimal essential medium in 7.5% fetal calf serum. COS-1 cells were transfected by a calcium phosphate coprecipitation technique, and P19 EC cells were transfected with liposomes (Lipofectamine; Gibco BRL) as indicated in the appropriate figure legends. ␤-Galactosidase and luciferase assays were performed as described previously (13) .
REE transformation assay. Primary rat embryonic fibroblasts (REFs) were purchased from BioWhittaker and maintained in Dulbecco modified Eagle medium containing 10% fetal calf serum. After one passage, secondary REFs were transfected by the calcium phosphate method with 2 g of Ha-ras, 2 g of RSVN-myc wild type or mutant as indicated, 5 g of appropriate receptor, and pBluescript II KS as a carrier for a total of 20 g per 100-mm-diameter tissue culture dish. The transfected REFs were washed, fresh medium was added 16 h after transfection, and cultures were split 1:3 24 h later. Numbers of foci were determined 10 days after the transfection.
Northern blot analysis. Total RNA was collected from cells transiently transfected with high efficiency (monitored by measuring ␤-galactosidase activity) by using a Pharmacia RNA extraction kit or TRIZOL (Gibco BRL) according to the manufacturer's instructions. RNA samples (10 g of total RNA) were electrophoresed through a 1% formaldehyde-1ϫ MOPS (morpholinepropanesulfonic acid)-1% agarose gel and transferred to a nylon membrane in 20ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate). RNA was UV cross-linked to the membrane and hybridized at 42ЊC to the appropriate random-primed probe (10 6 cpm ml
Ϫ1
) in 50% formamide-5ϫ Denhardt's solution-5ϫ SSPE (1ϫ SSPE is 0.18 M NaCl, 10 mM NaH 2 PO 4 , and 1 mM EDTA [pH 7.7])-0.1% sodium dodecyl sulfate (SDS)-100 g of denatured salmon sperm DNA per ml. The membranes were washed once for 20 min at room temperature with 2ϫ SSC-0.1% SDS and twice at 65ЊC in 0.2ϫ SSC-0.1% SDS for 15 min each time. Autoradiography was carried out at Ϫ70ЊC with an intensifying screen. An oligonucleotide hybridizing to the 18S rRNA (5Ј-ACGGTATCTGATCGTCTT CGAACC-3Ј) was used to control for RNA loading.
Nucleotide sequence accession numbers. GenBank accession numbers for human and mouse N-myc are Y00664 and M12731, respectively.
RESULTS

ROR␣1
and RVR bind to the N-myc RORE. Our molecular studies of orphan receptor function have led us to identify consensus DNA binding sites for ROR␣1 and RVR (referred to as a RORE) (10, 36) . One approach to identify target genes for nuclear receptors consists of scanning databases for the presence of consensus DNA binding sites in regulatory sequences of cloned transcription units. This strategy led to the localization of a RORE within a region of the first intron of the N-myc gene implicated in the regulation of its expression ( Fig.  1 ) (16) . Although the first introns of the human and mouse N-myc genes have only a very limited degree of homology, the consensus RORE (hereafter referred to as human or mouse N-myc RORE) is extremely well conserved in the two species, suggesting an important regulatory function (Fig. 1C) .
To test whether ROR␣1 and RVR can interact with the N-myc RORE, we performed EMSA using in vitro-synthesized ROR␣1 and RVR and synthetic 32 P-labeled oligonucleotides representing RORE␣2, the element originally described as the consensus binding site for ROR␣1 (14) , as well as the human and mouse N-myc ROREs. As shown in Fig. 2 , lane 2, ROR␣1 binds strongly to the positive control, RORE␣2, and the binding is specifically competed by addition of a 100-fold excess of unlabeled synthetic oligonucleotides representing RORE␣2 and human and mouse N-myc ROREs (lanes 4 to 6). Similarly, ROR␣1 binds to the human (lane 8) and mouse (lane 14) N-myc ROREs, and in each case binding is competed specifically by unlabeled RORE␣2 and by human and mouse N-myc RORE oligonucleotides (lanes 10 to 12 and 16 to 18). ROR␣1 bound to the mouse N-myc RORE with higher affinity than to the human N-myc RORE (compare lanes 8 and 14) . Moreover, the human N-myc RORE was a less efficient competitor than either the RORE␣2 or the mouse N-myc RORE (for example, compare lane 17 with lanes 16 and 18). VOL. 17, 1997 N-myc REGULATION BY NUCLEAR RECEPTORSROR␣1 and RVR have opposite transcriptional activities on N-myc RORE. To confirm that the human and mouse N-myc ROREs confer responsiveness to ROR␣1 and RVR, we linked one or three copies of the N-myc ROREs upstream of the thymidine kinase promoter and the luciferase reporter gene. These reporter constructs were then tested by transfection in COS-1 cells together with ROR␣1 and RVR expression vectors (Fig. 3) . Transfection of the RVR expression vector resulted in significant repression of basal promoter activity with mouse ( Fig. 3A and B) and human (Fig. 3C ) N-myc RORE reporter constructs. As expected, when ROR␣1 expression vector was cotransfected, a fourfold induction of luciferase activity over basal levels was observed with the human N-myc RORE construct (Fig. 3C ). Higher levels of ROR␣1 responsiveness (Ͼ10-fold) were observed when the mouse N-myc RORE was tested (Fig. 3B) . To investigate whether RVR could repress ROR␣1-induced transcriptional activity on the human and mouse N-myc elements, we transfected increasing amounts of RVR with constant levels of ROR␣1 together with the human or the mouse N-myc RORE reporter. We found that RVR could efficiently decrease ROR␣1-induced transcriptional activity from both human and mouse N-myc ROREs (Fig. 3) .
To further assess the specificity of these interactions, we generated a pair of oligonucleotides harboring point mutations in the mouse N-myc RORE (Fig. 4A) . Figure 4B demonstrates that both ROR␣1 (lane 3) and RVR (lane 6) failed to interact with the mutated RORE in EMSA and also failed to repress (RVR) or activate (ROR␣1) transcription from it in transient transfection experiments (Fig. 4C) .
ROR␣1 and RVR regulate N-myc gene expression. To test the hypothesis that the N-myc RORE is functional and that the N-myc gene is responsive to ROR␣1 and RVR, we transfected into COS-1 cells the entire mouse N-myc transcription unit (a 7.3-kb EcoRI genomic fragment) together with ROR␣1 and RVR expression vectors, singly or in combination. Northern blot analysis revealed that cotransfection of ROR␣1 causes a significant increase in N-myc transcript levels (Fig. 5, lane 2) . In contrast, introduction of the RVR expression vector led to a reduction in N-myc mRNA levels (Fig. 5, lane 3) and antagonized the stimulatory effects of ROR␣1 (Fig. 5, lane 4) . These effects were mediated by the N-myc RORE, since mutation of this site abolished both the ROR␣1-and RVR-mediated responses (Fig. 5, lanes 5 to 8) .
To study the effects of ROR␣1 and RVR on the expression of the endogenous N-myc gene in vivo, we took advantage of the P19 cell line, which expresses the N-myc gene. We used Lipofectamine to transfect a large proportion (Ͼ50%) of P19 cells and coexpressed ROR␣1 and RVR, alone or in combination. Northern blot analysis demonstrated that transiently transfected RVR can repress the endogenous N-myc gene (Fig. 6, lane 3) . However, ROR␣1 alone did not seem to influence N-myc transcription (Fig. 6, lane 2) but could reverse the inhibitory effect of RVR (Fig. 6, lane 4) . Since P19 EC cells 8, and 14) . Radiolabeled mouse N-myc RORE was incubated with RRL programmed with RVR (lane 20). Probes were also incubated with unprogrammed lysate as a control (lanes 1, 7, 13, and 19). Unlabeled RORE␣2 (R; lanes 4, 12, and 18), human N-myc RORE (hN; lanes 5, 10, and 17), and mouse N-myc RORE (mN; lanes 6, 11, 16, and 22) as well as a nonspecific competitor (NS; lanes 3, 9, 15, and 21) were used at 100-fold molar excess. express ROR␣ (7, 28) , it is possible that N-myc expression is at or near its highest level, and therefore only repression can be observed. Taken together, these results indicate that ROR␣1 and RVR can compete to regulate the expression of the N-myc gene in the context of its own regulatory sequences.
ROR␣1 potentiates N-myc oncogenic potential. To further demonstrate that ROR␣1 and RVR are functional regulators of N-myc transcription, we used a quantitative biological assay based on the ability of N-myc to transform REFs in cooperation with activated Ha-ras (3, 38, 49) . We therefore decided to compare the numbers of foci generated with wild-type and RORE-deficient N-myc genes. We show that transformation in the presence of the RORE-deficient N-myc gene results in a fourfold increase in the number of foci compared to the wildtype N-myc (Fig. 7A) . Furthermore, these foci were significantly larger than those produced by wild-type N-myc (data not shown). To test whether this increase in foci number with RORE-deficient N-myc was due to the loss of a site for a transcriptional repressor, we decided to verify if ROR␣1 and/or RVR could play a role in N-myc transformation in the REF assay. Activation and/or inhibition of N-myc activity was assessed by comparing the numbers of transformed foci generated in cotransfections containing wild-type or mutated Nmyc and activated Ha-ras in the presence of ROR␣1 and/or RVR. We observed that when ROR␣1 was coexpressed with wild-type N-myc, a twofold increase in the number of foci was detected compared to REFs transformed with Ha-ras and Nmyc alone (Fig. 7B) . In contrast, when RVR was transfected with wild-type N-myc, the same number of foci was formed as in cells not expressing RVR (Fig. 7B) . In this assay, RVR only slightly altered ROR␣1 action. However, unlike foci generated with Ha-ras and wild-type N-myc in the absence or presence of ROR␣1, very few foci expressing RVR could be expanded in culture (Fig. 7C) . When RVR was coexpressed with Ha-ras and the RORE-deficient N-myc gene, the foci produced established cell lines with greater efficiency than foci transformed with wild-type N-myc (Fig. 7C) . These results indicate that the effects of RVR on cellular activities are via N-myc through its RORE. 5 and 6) . The probes were also incubated with unprogrammed lysate (lanes 1 and 4) . (C) COS-1 cells were transfected with 1 g of expression vector and 2 g of reporters containing three copies of either the wild-type (mN) or mutated (mN m1 ) N-myc RORE upstream of TKLUC. Luciferase values were normalized to ␤-galactosidase activity. The experiments were repeated three times. Standard deviations were less than 10%.
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DISCUSSION
RVR has been shown to interfere with ROR␣1-induced transcriptional activity in transient transfections using synthetic response elements linked to reporter genes, suggesting that these two orphan receptors may regulate differentially a common set of genes (36) . In an attempt to understand their physiological functions, we aimed to identify natural target genes. Using a database search and interspecies DNA sequence comparisons, we have identified a binding site for these two orphan receptors in the first intron of the N-myc gene. Our results have clearly demonstrated that the N-myc RORE is functional in vivo and that ROR␣1 and RVR differentially regulate the expression of N-myc. These observations identify for the first time transcription factors, members of the superfamily of nuclear hormone receptors, that specifically interact with the N-myc gene. In addition, this work firmly establishes the existence of an orphan nuclear receptor-based signaling pathway that can regulate the expression of specific gene networks through competition between transcriptional activators and repressors for the same recognition site.
We have shown that ROR␣1 and RVR directly modulate N-myc expression. An exogenous N-myc gene transiently introduced into COS-1 cells was up-regulated by ROR␣1 and down-regulated by RVR. More importantly, RVR was also able to down-regulate the endogenous N-myc gene in P19 EC cells. The transcriptional effects of ROR␣1 and RVR on the N-myc gene must be mediated through the N-myc RORE, since mutation of this element abolished the transcriptional activity of both transcription factors in COS-1 cells. The N-myc RORE is configured as a monomeric nuclear receptor binding site, containing a single PuGGTCA core motif preceded by a 6-bp AT-rich sequence. That RVR can repress the expression of a gene containing a single copy of a monomeric nuclear receptor binding site is an important observation. It has recently been suggested that Rev-Erb␣, whose structure and mechanisms of action are similar to those of RVR, acts efficiently as a basal repressor of a promoter linked to a hormone response element (HRE) configured as a direct repeat spaced by two nucleotides (DR-2) (15). RVR also shares with RevErb␣ the ability to bind as a homodimer and function as a repressor on a DR-2 (7). However, our data clearly indicate that RVR, in the context of a natural and functional transcription unit, can also act as an active repressor when bound to a monomeric HRE. This is demonstrated by the observation that expression of RVR in COS-1 cells down-regulates N-myc but that ablation of the N-myc RORE has no effect on its expression (Fig. 5) . If squelching or simple competition for binding site occupancy of an activator were responsible for RVR action in these cells, we would predict lower basal N-myc expression in the absence of the RORE. That RVR can function as an active repressor is further supported by the recent finding that ligand-independent transcriptional repression by Rev-Erb␣ is potentiated by the corepressor N-CoR through direct proteinprotein interaction (50) . However, competition for binding site occupancy remains an important mechanism of action for ROR and RVR in cells where the two receptors are coexpressed. Taken together, these observations define Rev-Erb␣ and RVR as a class of transcriptional repressors that can function in both the monomeric and the dimeric state. The specific configuration of the RORE, a single PuGGTCA motif preceded by a 6-bp AT-rich region, also suggests that the interactions between this element and nuclear receptors may be specific to members of the ROR and Rev-Erb subfamilies. To date, no other members of the superfamily of nuclear receptors have been demonstrated to recognize this form of monomeric HRE.
The importance of the RORE in the control of expression of the N-myc gene is also strengthened by its conservation across species. Our results have demonstrated that both ROR␣1 and RVR specifically bind to the human and mouse N-myc ROREs. However, ROR␣1 has a slightly greater affinity for the mouse N-myc RORE than for the human counterpart. This may be due to the G residue at position ϩ1 of the hexamer PuGGTCA and/or to the C at position Ϫ6 of the human N-myc RORE, since these are the only two changes with respect to the RORE␣2, the ideal consensus site originally defined for ROR␣1 (Fig. 1) (14) . Although a G at position ϩ1 permits binding of ROR␣1 to the RORE, the site most often selected for binding contains an A at this position. Furthermore, a T or an A at position Ϫ6 results in higher-affinity binding (14) . The stronger binding ability of ROR␣1 to mouse N-myc RORE was reflected by a stronger transactivation of the mouse N-myc luciferase reporter construct by ROR␣1. However, although the mouse N-myc RORE gave better responsiveness, the human N-myc RORE behaved identically; i.e., ROR␣1 activated and RVR repressed transcription from both human and mouse N-myc RORE reporter constructs. In addition, RVR interfered with ROR␣1-induced transcriptional activity on both reporters, consistent with previous studies by us (14) and others (8) using an ideal synthetic element.
That the N-myc RORE acts as an essential regulatory element of the N-myc gene in vivo comes from our observation that when the RORE was functionally impaired by mutations, the N-myc gene became more oncogenic. This phenomenon has previously been observed in the REF assay using N-myc gene deletion constructs (46) . In this study, an increase in steady-state mRNA after the removal of a stem-loop structure present in the first exon was observed, and therefore a loss of transcriptional attenuation was proposed to be partially responsible for this phenomenon. To observe a large increase in the number of foci, the entire first exon and intron had to be removed, suggesting the presence of other cis-acting elements (46) . The N-myc RORE is also distinct from a silencer element, located in the first intron of human N-myc, that dictates cell-type-specific activity to the N-myc promoter (45) . In contrast to the RORE, the short DNA sequence encoding the proposed silencer (AGCCTCTCC) is not conserved between humans and rodents. These previous studies as well as our present observations suggest multiple modes of regulation of the N-myc gene.
That the RORE appears to play an important role in N-myc regulation may have important implications for the normal and abnormal biology of both orphan nuclear receptors and N-myc. It will be of interest to compare the patterns of expression of all members of the ROR and Rev-Erb subfamilies with that of N-myc during early embryonic development as well as to investigate whether RVR and Rev-ErbA␣ contribute to the silencing of N-myc expression in adult tissues. It is also conceivable that deregulation of ROR␣1 and/or RVR can directly affect N-myc expression. Overexpression of ROR␣1, or loss of RVR, could lead to inappropriate expression of N-myc such as is the case in retinoblastoma, neuroblastoma, and SCLC. For example, N-myc gene amplification and overexpression are common events in SCLC. Genetic alterations associated with SCLC are numerous but always include deletions in the short arm of chromosome 3 (9) . Deletion of this region is a very early event in the pathogenesis of lung cancer as it is detected in hyperplastic lung tissue (19) . However, N-myc gene amplification and expression are often observed later in the course of the disease (34) , suggesting that loss of 3p may be a prerequisite for N-myc expression. We have recently localized RVR to a region of mouse chromosome 14 which is in synteny with human chromosome 3p24 (11) , suggesting that the RVR gene may be nonfunctional in SCLC and therefore can contribute to neoplastic transformation. The REF assay also demonstrated that RVR can repress N-myc expression. In all cases, when RVR was coexpressed with Ha-ras and wild-type N-myc, very few foci could be passaged in culture. In contrast, RVR had no effect on the number or morphology of the foci when coexpressed with Ha-ras and N-myc with a mutated RORE. Taken together, these observations suggest that RVR can be considered a candidate tumor suppressor gene, a possibility that warrants further studies on the status of the RVR gene in tumors overexpressing N-myc.
In conclusion, we have identified two transcription factors, ROR␣1 and RVR, that specifically interact with a novel regulatory element in the N-myc gene and differentially regulate its expression. Moreover, the cis-and trans-acting elements that we have identified may have physiological relevance to the development and progression of tumors expressing N-myc. These findings raise the possibility that in the event that natural and/or synthetic ligand/activators specific for these orphan FIG. 7 . The N-myc RORE is important for the oncogenic activity of N-myc. (A) REFs were transfected with 2 g of wild-type (mN-myc) or mutated (mN m1 -myc) N-myc gene and 2 g of activated Ha-ras. The number of foci was recorded from three individual experiments that included 10 100-mm-diameter plates/group/ experiment. (B) REFs were transfected with 2 g of N-myc gene, 2 g of activated Ha-ras, 5 g of pCMXROR␣1, 5 g of pCMXRVR, or 5 g of each expression vector. The total number of foci from six individual experiments that included 10 plates/group/experiment is represented. (C) Percentage of permanent clones established from foci transformed with wild-type (WT) and RORE-deficient (mN m1 -myc) N-myc genes. Twenty-four foci were picked from each group, trypsinized, and plated into 24-well tissue culture plates. The clones were passaged every other day for 1 week and were subsequently transferred to 60-mm-diameter dishes. Permanent clones were those that grew at a high rate in 60-mm-diameter dishes for an additional 10 days.
receptors are discovered, pharmacological agents could be used as therapeutic modalities for malignancies in which the N-myc transcript is overexpressed.
